5.230 <%= Resources.Global.txtDown %>
Updated 16/09/2019
Change % -0.19% Stock price decreasing
Change -0.01 Stock price decreasing
Volume 204,896
High 5.390
Low 5.020
Open 5.320
ISIN FR0013018124
Prev close 5.240
# of shares 29.91M
Market cap 156.45M EUR

Market closed
Market is closed, opens at 08:00
Price development Latest 1 week 1 month 3 months 6 months 1 year
  5.23 4.6% Stock price increasing 20.0% Stock price increasing 5.5% Stock price increasing -13.1% Stock price decreasing -28.7% Stock price decreasing
Powered by TradingView

News about Nicox

  • English
  • Regulatory news

Company profile

Nicox SA is a France based ophthalmic corporation. It is focused on operating in the ophthalmic market through a diversified portfolio of ophthalmic products. The company's pipeline features VESNEO for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension; AC-170 for the treatment of ocular itching associated with allergic conjunctivitis; AzaSite for bacterial conjunctivitis; and BromSite for pain and inflammation after cataract surgery. The group operates internationally and is also focused on developing a pipeline of ophthalmology-focused candidates which utilize its proprietary nitric oxide-donating research platform.

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
18 September 2019 06:49:28
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190829.2 - EUROWEB6 - 2019-09-18 07:49:28 - 2019-09-18 06:49:28 - 1000 - Website: OKAY